Week in Review: AI in developing nations | Tribunal suspends researcher | MRI of liver cirrhosis

Dear AuntMinnieEurope Member,

AI’s potential is particularly great in developing countries, where hospitals often lack an in-house radiologist, and this is underlined perfectly by an initiative in Tanzania that has helped improve diagnosis of tuberculosis.

The project is also a neat example of how European collaboration can lead to positive results. Get the full story in this Q&A interview.

This week’s most popular article is about a U.K. tribunal’s decision to suspend an AI researcher who currently works for Google Health in Ireland. There appeared to be a relatively strong case for striking off Dr. Cían Hughes from the medical register, but after a long evaluation of the entire facts, the tribunal opted for a 12-month suspension.

Liver cirrhosis is becoming more common and in some countries is a significant cause of hospitalization and death, especially after middle age. But what’s the connection between liver dysfunction and cardiac damage? A German study has provided some answers.

In other news, Dutch authors have found that compared with plaques without calcification, plaques that already had calcification were twice as likely to develop internal bleeding, a key indicator of plaque vulnerability and potential rupture. Also, men are more likely to have plaques that evolve to multicomponent plaques with intraplaque hemorrhage, they say.

Finally, U.K. researchers have examined the efficacy of infliximab for the treatment of steroid-refractory cardiac sarcoidosis using serial quantitative F-18 FDG-PET/CT imaging. Their findings deserve a close look.

Philip Ward
Editor in Chief
AuntMinnieEurope.com

Page 1 of 1